ABSTRACT
PURPOSE: Acceleration of MRI acquisitions and especially of T2-weighted sequences is essential to reduce the duration of MRI examinations but also kinetic artifacts in liver imaging. The purpose of this study was to compare the acquisition time and the image quality of a single-shot fat-suppressed turbo spin-echo (TSE) T2-weighted sequence with deep learning reconstruction (HASTEDL) with that of a fat-suppressed T2-weighted BLADE TSE sequence in patients with focal liver lesions. MATERIALS AND METHODS: Ninety-five patients (52 men, 43 women; mean age: 61 ± 14 [SD]; age range: 28-87 years) with 42 focal liver lesions (17 hepatocellular carcinomas, 10 sarcoidosis lesions, 9 myeloma lesions, 3 liver metastases and 3 focal nodular hyperplasias) who underwent liver MRI at 1.5 T including HASTEDL and BLADE sequences were retrospectively included. Overall image quality, noise level in the liver, lesion conspicuity and sharpness of liver lesion contours were assessed by two independent readers. Liver signal-to-noise ratio (SNR) and lesion contrast-to-noise ratio (CNR) were measured and compared between the two sequences, as well as the mean duration of the sequences (Student t-test or Wilcoxon test for paired data). RESULTS: Median overall quality on HASTEDL images (3; IQR: 3, 3) was significantly greater than that on BLADE images (2; IQR: 1, 3) (P < 0.001). Median noise level in the liver on HASTEDL images (0; IQR: 0, 0.5) was significantly lower than that on BLADE images (1; IQR: 1, 2) (P < 0.001). On HASTEDL images, mean liver SNR (107.3 ± 39.7 [SD]) and mean focal liver lesion CNR (87.0 ± 76.6 [SD]) were significantly greater than those on BLADE images (67.1 ± 23.8 [SD], P < 0.001 and 48.6 ± 43.9 [SD], P = 0.027, respectively). Acquisition time was significantly shorter with the HASTEDL sequence (18 ± [0] s; range: 18-18 s) compared to BLADE sequence (152 ± 47 [SD] s; range: 87-263 s) (P < 0.001). CONCLUSION: By comparison with the BLADE sequence, HASTEDL sequence significantly reduces acquisition time while improving image quality, liver SNR and focal liver lesions CNR.
Subject(s)
Carcinoma, Hepatocellular , Deep Learning , Liver Neoplasms , Adult , Aged , Aged, 80 and over , Artifacts , Female , Humans , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/secondary , Magnetic Resonance Imaging/methods , Male , Middle Aged , Retrospective StudiesABSTRACT
OBJECTIVES: To evaluate the reliability of attenuation values of the liver parenchyma and focal liver lesions on virtual unenhanced images from arterial (VUEart) and portal venous phases (VUEport) compared to native unenhanced (NU) attenuation values in patients referred for assessment of malignant liver lesions. METHODS: Seventy-three patients with confirmed primary or metastatic liver tumors who underwent a multiphase contrast-enhanced rapid-switching kVp dual-energy CT (rsDECT) were included in this IRB-approved retrospective study. Both qualitative and quantitative analyses - including the lesion-to-liver contrast-to-noise ratio (LL-CNR) - were performed and compared between NU and both VUEart and VUEport images. RESULTS: The mean liver attenuation values were significantly lower in VUEart images (56.7⯱â¯6.7 HU) than in NU images (59.6⯱â¯7.5 HU, pâ¯=â¯0.008), and were comparable between VUEart and VUEport images (57.9⯱â¯6 UH, pâ¯=â¯0.38) and between VUEport and NU images (pâ¯=â¯0.051). The mean liver lesions attenuation values were comparable between NU, VUEart and VUEport images (pâ¯=â¯0.60). Strong and significant correlations values were found both in liver lesions and tumor-free parenchyma (râ¯=â¯0.82-0.91, pâ¯<â¯0.01). The mean LL-CNR was significantly higher in VUEart and VUEport images than in NU images (1.7⯱â¯1 and 1.6⯱â¯1.1 vs 0.9⯱â¯0.6; pâ¯<â¯0.001), but was comparable between VUEart and VUEport images (pâ¯>â¯0.9). Lesion conspicuity was significantly higher in VUEport images than in NU images (pâ¯<â¯0.001). CONCLUSION: VUEport images derived from 3rd generation rsDECT could confidently replace NU images in patients undergoing assessment for malignant liver lesions. These images provide comparable attenuation values in both liver lesions and liver parenchyma while reducing the radiation dose and scanning time.
Subject(s)
Liver Neoplasms , Radiography, Dual-Energy Scanned Projection , Contrast Media , Humans , Liver Neoplasms/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted , Reproducibility of Results , Retrospective Studies , Tomography, X-Ray ComputedABSTRACT
PURPOSE: The purpose of our study was to correlate the quantitative analysis of benign hepatocellular tumor uptake on delayed hepatobiliary phase (HBP) imaging with the quantitative level of OATP expression. METHODS: This single-center retrospective study, which took place between September 2009 and March 2015, included 20 consecutive patients with a proven pathologic and immunohistochemical (IHC) diagnosis of FNH or HCA, including quantification of the OATP expression. The patients underwent Gd-BOPTA-enhancement MRI, including an HBP. The analysis of HBP uptake was performed using the liver-to-lesion contrast enhancement ratio (LLCER). Mean LLCER and OATP expressions were compared between FNH and HCA, and the expression of OATP was correlated with the LLCER value. RESULTS: Of the 23 benign hepatocellular tumors, 9 (39%) were FNH and 14 (61%) were HCA, including 6 inflammatory, 2 HNF1a inactivated, 3 ß-catenin-mutated and 3 unclassified HCAs. On HBP, 100% of the FNH appeared hyper- or isointense, and 79% of the adenomas appeared hypointense. The mean OATP expression of FNH (46.67 ± 26.58%) was significantly higher than that of HCA (22.14 ± 30.74%) (p = 0.0273), and the mean LLCER of FNH (10.66 ± 7.403%) was significantly higher than that of HCA (-13.5 ± 12.25%) (p < 0.0001). The mean LLCER of ß-catenin-mutated HCA was significantly higher than that of other HCAs (p = 0.011). Significant correlation was found between the OATP expression and LLCER values (r = 0.661; p = 0.001). CONCLUSION: In benign hepatocellular tumors, the quantitative analysis of hepatobiliary contrast agent uptake on HBP is correlated with the level of OATP expression and could be used as an imaging biomarker of the molecular background of HCA and FNH. KEY POINTS: ⢠Gd-BOPTA uptake on HBP correlates with the OATP level in benign hepatocellular tumors ⢠FNH and ß-catenin-mutated HCA showed an increased lesion-to-liver contrast enhancement ratio (LLCER) ⢠Increased LLCER may be explained by activation of the Wnt ß-catenin pathway.
Subject(s)
Carcinoma, Hepatocellular/diagnostic imaging , Contrast Media/administration & dosage , Focal Nodular Hyperplasia/diagnostic imaging , Gadolinium DTPA/administration & dosage , Liver Neoplasms/diagnostic imaging , Meglumine/analogs & derivatives , Organometallic Compounds/administration & dosage , Adenoma, Liver Cell/diagnostic imaging , Adenoma, Liver Cell/metabolism , Adult , Aged , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Diagnosis, Differential , Female , Focal Nodular Hyperplasia/metabolism , Focal Nodular Hyperplasia/pathology , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Magnetic Resonance Imaging/methods , Male , Meglumine/administration & dosage , Middle Aged , Organic Anion Transporters/metabolism , Retrospective Studies , Sensitivity and SpecificitySubject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Agents/therapeutic use , Cryptococcosis/complications , Cryptococcus neoformans , Lung Diseases, Fungal/complications , Opportunistic Infections/complications , Sezary Syndrome/complications , Sezary Syndrome/drug therapy , Skin Neoplasms/drug therapy , Aged , Alemtuzumab , Antibodies, Monoclonal, Humanized/administration & dosage , Antineoplastic Agents/administration & dosage , Cryptococcosis/drug therapy , Female , Humans , Lung Diseases, Fungal/drug therapy , Opportunistic Infections/drug therapyABSTRACT
Diffusion-Weighted-Imaging (DWI) assesses proton motion on a cellular scale. Owing to recent instrumentation developments, diffusion sequences are now routinely used for liver imaging. This review will go through the physical principles that underlie this technique, and then highlight up-to-date liver applications including quantification of liver fibrosis, focal lesions detection and characterization, and therapy response monitoring.
Subject(s)
Diffusion Magnetic Resonance Imaging , Liver Diseases/pathology , HumansABSTRACT
OBJECTIVES: The aim of this pilot study was to assess post-treatment apparent diffusion coefficient (ADC) changes of diffuse large B-cell lymphoma lesions on respiratory-gated whole-body diffusion-weighted imaging (DWI), with integrated (18)F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (PET/CT) as the reference standard. MATERIALS AND METHODS: A total of 15 patients underwent both whole-body DWI (b = 50, 400, 800 s/mm(2)) and PET/CT before initiation and after 4 cycles of chemotherapy. ADC of residual masses (lymph node and organ lesions) was assessed both visually and quantitatively, including measurement of mean ADC (ADC).(Figure is included in full-text article.) RESULTS: After chemotherapy, among 85 examined lymph node regions, residual nodes were present in 62 (73%) regions on DWI. Of these 62 regions, 26 had persistent lymph nodes with longest transverse diameter >10 mm, ie, positive based on DWI size criteria. The mean ADC of these 26 regions increased from 0.658 × 10(-3) ± 0.153 mm(2)/s (standard deviation) at baseline to 1.501 × 10(-3) ± 0.307 mm(2)/s (paired t test, P < 0.0001). Only 6 of these 26 regions were considered positive on PET/CT. Combining visual ADC analysis to size criteria reduced the number of false-positive results of DWI from 20 to 2 regions. For organ involvement, ADC values also increased compared with baseline (1.558 × 10(-3) ± 0.424 mm(2)/s vs. 0.675 × 10(-3) ± 0.135 mm(2)/s, respectively; P = 0.0009). CONCLUSIONS: Whole-body DWI with ADC mapping can show a significant increase in ADC values of residual masses persisting after treatment and may help to assess the treatment response in patients with diffuse large B-cell lymphoma.
Subject(s)
Diffusion Magnetic Resonance Imaging/methods , Lymphoma, Large B-Cell, Diffuse/diagnosis , Adult , Aged , Antineoplastic Agents/therapeutic use , Diffusion Magnetic Resonance Imaging/instrumentation , Female , Fluorodeoxyglucose F18 , Humans , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Middle Aged , Pilot Projects , Positron-Emission Tomography , Prospective Studies , Statistics, Nonparametric , Time Factors , Tomography, X-Ray Computed , Young AdultABSTRACT
Extramedullary haematopoiesis (EMH) is a reactive mechanism by which blood cells are produced outside of the bone marrow to supplement insufficient production or increased destruction of erythrocytes. EMH is uncommon in sickle cell anaemia (SCA). We report the first case of focal intra-hepatic EMH in SCA depicted on MRI occurring in a 32-year-old woman with homozygote SCA and in view of previously published data, highlight the diagnostic features suggesting a differential diagnosis with other focal liver lesions including infectious, inflammatory or primary liver tumors.
Subject(s)
Anemia, Sickle Cell/complications , Hematopoiesis, Extramedullary , Magnetic Resonance Imaging , Adult , Female , Humans , LiverABSTRACT
The identification of dilatations of the intrahepatic bile ducts in the absence of bile duct obstruction is rare. Imaging techniques, especially MR cholangio-pancreaticography, generally permit the distinction between fibrocystic liver diseases and polycystic liver diseases. The presence of dilated sacciform or tubular bile ducts on cholangio-pancreaticography associated with a centrally located fibrovascular bundle (central dot sign) suggests Caroli's syndrome. The presence of associated signs of liver dysmorphia including right lobe atrophy and hypertrophy of segment IV suggests associated congenital hepatic fibrosis. The findings on cholangio-pancreaticography, computerized tomography or Doppler ultrasonography correlate well with the pathogenesis of fibrocystic liver diseases, linked to an embryologic malformation of the ductal plate.